The largest database of trusted experimental protocols

Lithium chloride (licl)

Manufactured by Merck Group
Sourced in United States, Germany, United Kingdom, China, France, Sao Tome and Principe, Italy, Australia, Spain, Canada, Belgium, New Zealand, Macao, Denmark, Switzerland, Chile

LiCl is a chemical compound consisting of lithium and chlorine. It is a crystalline solid that is highly soluble in water and other polar solvents. LiCl is commonly used as a laboratory reagent and in various industrial applications.

Automatically generated - may contain errors

707 protocols using lithium chloride (licl)

1

Lithium Chloride Preconditioning of MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSCs were treated with lithium chloride (Sigma‐Aldrich, St. Louis, Missouri) or saline as control, using a slightly modified protocol published before.22, 31 Briefly, the preconditioning paradigm included incubation of MSCs from passages 3 to 5 with lithium chloride for 24 hours at a final concentration of 2.5 mM. Thereafter, lithium was washed out, and the cells received fresh cell culture medium without lithium chloride. Following the preconditioning paradigm, supernatants of so treated MSCs were harvested after an additional incubation for 2 days in order to enrich for EVs as described in Section 2.3.
+ Open protocol
+ Expand
2

ALS Cell Model Treated with LiCl and VPA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The plasmid of human SOD1 gene with G93A mutation is stably transfected into NSC34 cell line (Cedarlane Laboratories, Vancouver, BC, Canada), a hybrid cell line of mouse neuroblastoma and embryonic spinal motor neurons, named as SOD1 G93A (mtSOD1) NSC34 cell line. In this study, the mtSOD1 NSC34 cell line acted as a cell model of ALS, while NSC34 cell line transfected with wild type human SOD1 (WT) was used as control. The cells were cultivated in Dulbecco’s Modified Eagle’s Medium-High Glucose (GE Healthcare Life Sciences Hyclone, Pittsburgh, PA, USA) with 10% fetal bovine serum (FBS), 100 U/mL penicillin/streptomycin (GE Healthcare Life Sciences Hyclone), and 200 µg/mL of puromycin (G418, Life Technologies Corporation, Grand Island, NY, USA), which was selected to maintain the stable cell line translation. Cells were grown in a humidified atmosphere of 5% CO2 in air at 37 °C. mtSOD1 NSC34 cells were treated with LiCl (Sigma, St. Louis, MO, USA) 1.0 mM, VPA (Sigma) 0.6 mM, and LiCl plus VPA (LiCl 1.0 mM + VPA 0.6 mM), with 0.9% normal saline as control. After treatment for 72 h, mtSOD1 NSC34 cells were collected for further total RNA and protein extraction.
+ Open protocol
+ Expand
3

Effect of SrR on Wnt/β-catenin Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the effect of SrR on the Wnt/-catenin signaling pathway, we used XAV-939 (Selleck, China), an inhibitor of -catenin, at a concentration of 2.0 mmol/L and LiCl (Sigma, USA), an agonist of -catenin, at a concentration of 2.0mmol/L. Grouping was performed as follows: control, 0.25mmol/L SrR, 0.50mmol/L SrR, XAV-939, XAV-939 + 0.25mmol/L SrR, LiCl, and LiCl + 0.25mmol/L SrR. After 14days of induction, alcian blue and toluidine blue staining, immunofluorescence staining, hydroxyproline (Hyp) assays, PCR, and Western blot assays were performed.
+ Open protocol
+ Expand
4

Lithium Chloride-Pilocarpine Seizure Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
According to the lithium chloride-pilocarpine model [20 (link)], rats were first intraperitoneally (i.p.) injected with lithium chloride (127 mg/kg, Sigma-Aldrich, St. Louis, MO, USA) and pilocarpine (35 mg/kg, Sigma-Aldrich) 16–18 h later. Before 30 min pilocarpine injection, rats were given atropine (1 mg/kg, Aladdin-Holdings Group, Beijing, China) to block the peripheral effects of pilocarpine [21 ]. Rat convulsions were graded according to the Racine scale [22 (link)]. When grade IV or V appeared, it was considered as a generalized seizure, and regarded as status epilepticus (SE). When the duration of onset was 60 min or more, the kindling was deemed successful and stimulation was immediately stopped. Seizures were terminated using diazepam (7.5 mg/kg, i. p.) when rats experienced class IV seizures for 60 min. The control group was treated (i.p.) with the same dosage of saline.
+ Open protocol
+ Expand
5

Lithium Chloride Treatment for SCI

Check if the same lab product or an alternative is used in the 5 most similar protocols
At 1 day after surgery, the rats in the lithium group were injected intraperitoneally with 10 mL of phosphate buffered solution (PBS) containing 85 mg/kg lithium chloride (LiCl; Sigma-Aldrich Co., Gillingham, Dorset, UK) once a day. The sham and SCI groups received 10 mL of PBS.
+ Open protocol
+ Expand
6

Graphene Oxide and Polypyrrole Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Calcium chloride and lithium
chloride (∼99% anhydrous) were obtained from Sigma-Aldrich.
Sodium Alginate (SA, ≥99% with M/G = 1:2, 1:1, and 2:1) was
obtained from Shanghai Macklin Biochemical Co., Ltd. The following
chemicals were used for graphene oxide (GO) preparation: 99.9% metals
basis–10 mesh natural graphite flakes from Alfa Aesar (Germany),
potassium permanganate (99% KMnO4) from Fisher Scientific
(USA), hydrogen peroxide (35% H2O2), and various
acids, namely, sulfuric acid (97% H2SO4), phosphoric
acid (85% H3PO4), and hydrochloric acid (37%
HCl) from Merck (Germany). Ammonium persulfate, pyrrole, lithium chloride,
and HCl were acquired from Sigma-Aldrich and used for the preparation
of polypyrrole doped with chlorine (PPyCl).
+ Open protocol
+ Expand
7

Copper Oxide Nanostructures Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Copper(I) oxide (cuprous oxide, Cu2ONPs) and copper(II) oxide (cupric oxide, CuONSs) nanostructures
(NSs) were prepared by chronoamperometry (at room temperature using
a VoltaLab potentiostat PGZ301 and at a constant electrode potential
of 0.8 V for 4 h).51 (link),52 (link) 0.1 M aqueous solution of lithium
chloride (LiCl; from Sigma-Aldrich) was freshly prepared and used
for CuONS synthesis, while an ethanolic LiCl solution with 10% water
was freshly prepared and used for the synthesis of Cu2ONPs.
The electrochemical treatment was carried out under an inert atmosphere
by slowly bubbling the solution with argon gas in a conventional three-electrode
cell with a platinum wire as a counter electrode and an Ag/AgCl (1
M KCl) electrode as a reference electrode (the potential is indicated
against this electrode). A copper rod served as the working electrode.
Before electrochemical treatment, metallic copper (99.99% Cu) was
polished with sandpaper to reduce the grain size and then purified
in anhydrous ethanol (99.8%; from Sigma-Aldrich). The precipitated
product was in the form of orange Cu2ONPs and brown CuONSs.
+ Open protocol
+ Expand
8

Synthesis of Ti3C2Tx MXene Nanosheets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Suspensions
of Ti3C2Tx MXene nanosheets were synthesized using an etching bath made
of hydrofluoric acid (HF, VWR Chemicals), hydrochloric acid (HCl,
Sigma-Aldrich), and deionized (DI) water (Millipore, resistivity of
18 MΩ cm) to selectively etch away the Al layer from the parent
Ti3AlC2 MAX phase. In a high-density polyethylene
(HDPE) bottle, 2 g of Ti3AlC2 powder (<40
μm in particle size, Carbon-Ukraine Ltd.) was added to the premade
etchant solution (20 mL) and left for stirring at 40 °C for 16
h. Following the etching, the obtained suspensions of exfoliated MXene
nanosheets were carefully washed in DI water through several rounds
of centrifugation and decantation until a pH value of ca. 6 was attained.
Delaminated MXene nanosheets were then obtained using lithium chloride
(LiCl, Sigma-Aldrich) as an intercalant. Afterward, the dispersion
of LiCl-intercalated Ti3C2Tx nanosheets was washed once with DI
water, once with a DI water–methanol mixture (each 50 vol %),
and then washed twice with methanol (anhydrous, 99.8%, Sigma-Aldrich)
through centrifugation. Finally, the supernatant (in methanol) containing
delaminated Ti3C2Tx nanosheets was collected and stored at ca. −15
°C for further use.
+ Open protocol
+ Expand
9

Synthesis of Zirconium-based Solid Electrolytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
To prepare ZrO2(-ACl)-A2ZrCl6 (A = Li or Na), a stoichiometric mixture of Li2O (99.5%, Alfa Aesar) or Na2O (80%, Sigma Aldrich, ~20% Na2O2), LiCl (99.99%, Sigma Aldrich) or NaCl (99.99%, Alfa Aesar), and ZrCl4 (99.99%, Sigma Aldrich) was ball-milled at 600 rpm for 20 h in a ZrO2 vial with ZrO2 balls using Pulverisette 7PL (Fritsch GmbH) under Ar atmosphere. To prepare fluorinated HNSE ZrO2-2Li2ZrCl5F, a stoichiometric mixture (Li2O: ZrF4: ZrCl4 = 2: 0.5: 2.5) of Li2O (99.5%, Alfa Aesar), ZrF4 (99.9%, Sigma Aldrich) and ZrCl4 (99.99%, Sigma Aldrich) was ball-milled under the same condition as for the conventional HNSEs. To prepare nMyOz-Li2ZrCl6 nanomixtures, MyOz nanoparticles were ball-milled at 600 rpm for 20 h in a ZrO2 vial with ZrO2 balls using Pulverisette 7PL (Fritsch GmbH). ZrO2 (99.95%, 20 nm) and Al2O3 (≥95%, 50 nm) nanopowders were purchased from Avention and Sigma Aldrich, respectively. Fumed SiO2 powders were obtained from Sigma Aldrich. For the preparation of Li6PS5Cl, a stoichiometric mixture of Li2S (99.9%, Alfa Aesar), P2S5 (99%, Sigma Aldrich), and LiCl (99.99%, Sigma Aldrich) was ball-milled at 600 rpm for 10 h in a ZrO2 vial with ZrO2 balls, followed by annealing at 550 °C for 6 h under an Ar atmosphere.
+ Open protocol
+ Expand
10

Lithium and DKK1 Modulate Angiogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effects of LiCl and DKK1 on in vitro angiogenesis in the 3D collagen gel were determined by co-culturing GFP-ASCs and RFP-ECs, and the expression of angiogenic factors in a transwell model were determined by co-culturing hASCs and HUVECs; DMEM medium containing either 11.794 mmol·L−1 LiCl (0.5 mg·mL−1; Sigma-Aldrich) or DKK1 (100 ng·mL−1; R&D Systems, Minneapolis, MN, USA) was used.
The effects of LiCl and DKK1 on in vivo angiogenesis in an implanted gel were determined using concentrations of 47.176 mmol·L−1 (2 mg·mL−1) per animal and 200 ng·mL−1 per animal, respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!